CONNECT WITH US
HealthTech

HealthTech

Phthalate byproduct affects multiple cell types in human ovarian tissue, lab tests show

Medical Xpress logo

Published on

Add as a preferred source on Google
Phthalate byproduct affects multiple cell types in human ovarian tissue, lab tests show

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Common chemicals called phthalates, which are used in plastics, cosmetics and personal care products, may affect several different cell types in the human ovary. This is shown in a new study from Karolinska Institutet published in the journal eBioMedicine.

In the study, researchers investigated how MEHP, the primary breakdown product of the phthalate DEHP, affects human ovarian tissue.

Tissue samples from seven individuals were exposed to two concentrations of the substance. The lower concentration reflects levels commonly found in women in the general population. The researchers then analyzed more than 12,000 individual cells using a technique known as single-cell sequencing.

"Our results show that phthalates affect considerably more cell types in the ovary than the egg cells and follicles that have traditionally been the focus of research," says Pauliina Damdimopoulou, a professor in the Department of Women's and Children's Health at Karolinska Institutet and senior author of the study. "The most unexpected finding was that cells from the ovary's nervous system appeared to be particularly sensitive to the exposure."

The detailed single-cell analysis was conducted on tissue from one donor, although the findings were validated using additional tissue samples. To confirm the results, the researchers also carried out complementary experiments on cultured cells. The study examined only one of several breakdown products of DEHP.

Eleftheria Maria Panagiotou et al, Single-cell study of human ovarian response to phthalate exposure reveals glial cell susceptibility and disruption of adhesion and mitochondrial pathways, eBioMedicine (2026).


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.